TrumpRx: President Donald Trump has struck new deals with nine major drug companies. These agreements aim to reduce prescription drug prices for Medicaid recipients and those paying out of pocket. Companies like Merck and Bristol Myers Squibb are participating. This move seeks to align US drug prices with those in other wealthy nations. Savings are expected for commonly used medicines.